TEVA
Teva Pharma Industries Ltd
36.80$
+0.7%
vs. previous close
Closing price · As of: Aug 14, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +8.1% | -5.7% | -32.9% | -30.3% | -78.0% | +126.0% | -34.4% | +99.2% | -14.0% | -8.8% | +32.2% | |
| – | -13.3% | +16.5% | +38.6% | -12.8% | -77.4% | +274.3% | -14.6% | -1.7% | -11.9% | -8.2% | -5.4% | |
| – | +23.2% | +6.0% | +7.3% | +16.5% | -87.1% | +545.0% | -7.8% | +4.2% | -2.4% | +1.7% | +27.6% | |
| – | +512.8% | +28.2% | +876.1% | -72.5% | -66.7% | +256.1% | -89.4% | +89.0% | – | – | – | |
| – | +233.4% | +26.1% | -129.8% | – | – | – | – | – | -105.3% | – | – | |
| – | -16.9% | +16.7% | -3.0% | -25.5% | -81.7% | +385.7% | -2.8% | -2.5% | -4.0% | -5.3% | +0.6% | |
| – | +283.8% | +542.2% | – | -13.8% | -27.4% | -36.3% | +76.5% | -56.9% | +47.6% | -18.2% | -6.9% | |
| – | -0.1% | +34.9% | -25.5% | -98.1% | +136.4% | – | – | – | – | – | – | |
| – | -12.2% | – | -100.0% | – | +10.8% | – | – | – | – | – | – | |
| – | -67.9% | – | -119.0% | -34.3% | -43.1% | +0.9% | -10.9% | -18.3% | +24.3% | -3.5% | +10.5% | |
| – | – | +424.8% | -122.8% | -41.7% | -92.8% | +682.2% | +15.2% | -31.5% | +28.6% | -6.4% | +20.1% | |
| – | +297.3% | -226.2% | – | – | -10.4% | -72.5% | -89.6% | +2,928.6% | -38.2% | -81.4% | +250.7% | |
| – | +13.6% | -9.4% | -39.1% | -31.8% | -76.7% | +52.3% | -63.0% | +341.5% | -19.2% | -11.0% | +53.3% |
Data as of: August 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.